Summary of Group:

The Hematology Research and Early Development (R&D) team has the accountability for all drug development activities in hematology research from first in man studies, all the way to late-stage trials leading to drug approval by regulatory agencies (Phase 1, 2 and 3 trials). The team strives to deliver compelling preclinical, clinical and translational data packages providing confidence in the dosing strategy, tolerability profile and therapeutic efficacy of our candidate drugs to support investment in late-stage clinical development, leading to drug approval. 

Summary of Role: 

The Director, Strategic Projects & Organizational Enablement drives execution of strategic priorities across Clinical Development by leading cross-functional initiatives, enhancing operational performance, and ensuring alignment with Haematology goals. The role integrates planning, performance management, and financial oversight while enabling collaboration, in...